Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)

Peripheral T-cell lymphomas (PTCLs) are a group of highly aggressive malignancies with generally poor prognoses, and the first-line chemotherapy of PTCL has limited efficacy. Currently, several novel targeted agents, including histone deacetylase inhibitors (HDACis), have been investigated to improv...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Guang, Jin, Shikai, Lin, Suwen, Gong, Yuping, Zhang, Liwen, Yang, Jingwen, Mou, Weiwei, Du, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398948/
https://www.ncbi.nlm.nih.gov/pubmed/37533111
http://dx.doi.org/10.1186/s13148-023-01531-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398948/
https://www.ncbi.nlm.nih.gov/pubmed/37533111
http://dx.doi.org/10.1186/s13148-023-01531-8

Ejemplares similares